Focused Compounding Amends PRKA Stake, Signals Continued Influence

Ticker: PRKA · Form: SC 13D/A · Filed: Jan 30, 2024 · CIK: 1297937

Parks America, Inc SC 13D/A Filing Summary
FieldDetail
CompanyParks America, Inc (PRKA)
Form TypeSC 13D/A
Filed DateJan 30, 2024
Risk Levelmedium
Pages4
Reading Time5 min
Key Dollar Amounts$0.001
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: insider-ownership, amendment, activist-investing

TL;DR

**Focused Compounding is still a major player in PRKA, watch for potential changes!**

AI Summary

Focused Compounding Fund, LP, an investment fund managed by Geoff Gannon and Andrew Kuhn, filed an Amendment No. 4 to its Schedule 13D on January 26, 2024, regarding its ownership in Parks! America, Inc. This filing updates their previous disclosures, indicating a continued significant stake in the company. This matters to investors because Focused Compounding is a notable activist investor, and their ongoing involvement could signal potential future strategic changes or influence on Parks! America's management and operations.

Why It Matters

This filing shows that a significant institutional investor, Focused Compounding Fund, LP, continues to hold a substantial position in Parks! America, Inc., which could lead to pressure for operational improvements or strategic shifts.

Risk Assessment

Risk Level: medium — The risk is medium because while a large investor's involvement can be positive, it can also lead to disagreements with management or strategic shifts that may not always benefit all shareholders.

Analyst Insight

Investors should monitor future filings from Focused Compounding Fund, LP for any changes in their ownership percentage or stated intentions, as this could signal potential activist involvement or a shift in their investment thesis for Parks! America, Inc.

Key Players & Entities

  • Focused Compounding Fund, LP (company) — the investment fund filing the SC 13D/A
  • Parks! America, Inc. (company) — the subject company whose shares are being reported
  • Geoff Gannon (person) — authorized to receive notices for Focused Compounding Capital Management, LLC
  • Andrew Kuhn (person) — authorized to receive notices for Focused Compounding Capital Management, LLC
  • $0.001 (dollar_amount) — par value per share of Parks! America, Inc. Common Stock
  • January 26, 2024 (date) — date of the event requiring the filing of this statement

Forward-Looking Statements

  • Focused Compounding Fund, LP will continue to maintain a significant stake in Parks! America, Inc. (Focused Compounding Fund, LP) — high confidence, target: 2025-01-30
  • Focused Compounding Fund, LP may engage in further communications with Parks! America, Inc. management regarding strategic direction. (Parks! America, Inc.) — medium confidence, target: 2024-07-30

FAQ

What is the purpose of this specific filing, SC 13D/A?

This filing is an Amendment No. 4 to a Schedule 13D, meaning Focused Compounding Fund, LP is updating previously disclosed information regarding its beneficial ownership in Parks! America, Inc.

Who is the filer of this SC 13D/A?

The filer of this SC 13D/A is Focused Compounding Fund, LP, with its business address at 3838 Oak Lawn Avenue, Suite 1000, Dallas, TX 75219.

What is the subject company of this filing?

The subject company is Parks! America, Inc., with its business address at 1300 Oak Grove Rd, Pine Mountain, GA 31822.

What is the CUSIP number for Parks! America, Inc. common stock?

The CUSIP number for Parks! America, Inc. Common Stock is 701455107.

Who are the individuals authorized to receive notices and communications for the filing person?

Geoff Gannon and Andrew Kuhn of Focused Compounding Capital Management, LLC are authorized to receive notices and communications for the filing person.

Filing Stats: 1,125 words · 5 min read · ~4 pages · Grade level 11.4 · Accepted 2024-01-30 16:59:36

Key Financial Figures

  • $0.001 — me of Issuer) Common Stock, Par Value $0.001 per share (Title of Class of Securitie

Filing Documents

of the Schedule 13D is hereby amended and

Item 2 of the Schedule 13D is hereby amended and supplemented by adding the following: Reference is hereby made to Item 4, and the disclosure of the 2024 Annual Meeting Nominees. As described in Item 4, Focused Compounding submitted the 2024 Annual Meeting Nominees to the Company on January 26, 2024. Such nominees for election to the Board at the 2024 Annual Meeting are (i) Andrew Kuhn, (ii) Geoff Gannon, (iii) Jacob McDonough and (iv) Ralph Molina. Mr. McDonough, whose principal of the United States and beneficially owns no Shares. He is the founder and portfolio manager of McDonough Investments, a registered investment adviser. Mr. Molina, whose principal of the United States and beneficially owns no Shares. He currently serves as a senior investor relations analyst for The Cheesecake Factory (NASDAQ:CAKE). Neither Mr. McDonough nor Mr. Molina has been convicted in a criminal proceeding during the last five years, and neither of them during the past five years has been subject to a judgment, decree or final order relating to federal or state securities laws. Item 4. Purpose of Transaction

of the Schedule 13D

Item 4 of the Schedule 13D is hereby amended and supplemented by adding the following: Currently a special meeting of shareholders is scheduled to be held virtually on February 26, 2024 at 11:00 a.m. Eastern Time (the “Special Meeting”), and an annual meeting of shareholders is scheduled to be held virtually on June 6, 2024 at 10:00 a.m. ET (the “2024 Annual Meeting”). The Special Meeting As previously disclosed, Focused Compounding called the Special Meeting scheduled by Parks! to be held on February 26, 2024. The purpose of the Special Meeting, among other things, is to remove all of the current directors from the board of directors of the Company (the “Board”), and to elect Focused Compounding’s three nominees, Andrew Kuhn, Geoff Gannon and James Ford to replace the current Board. The 2024 Annual Meeting Subsequent to Focused Compounding submitting a notice to the Company requiring the Company to hold the Special Meeting, its first meeting of shareholders since October 19, 2010 – more than thirteen (13) years ago – the Company filed a Current Report on Form 8-K on January 16, 2024 disclosing that the Company will hold the 2024 Annual Meeting on June 6, 2024. In connection with the 2024 Annual Meeting, on January 26, 2024, Focused Compounding delivered a nomination letter to the Company providing notice that Focused Compounding intends to nominate four (4) director-nominees for election to the Board at the 2024 Annual Meeting, and that Focused Compounding intends to solicit votes in support of its nominees. Such nominees for election to the Board at the 2024 Annual Meeting are (i) Andrew Kuhn, (ii) Geoff Gannon, (iii) Jacob McDonough and (iv) Ralph Molina (the “2024 Annual Meeting Nominees”). SIGNATURE After reasonable inquiry and to the best of the knowledge and belief of the undersigned, the undersigned certifies that the information set forth in this statement is true, complete and corr

View Full Filing

View this SC 13D/A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.